Hereditary disorders of connective tissue: A guide to the emerging differential diagnosis

Genetics in Medicine

Volumn 12, Issue 6, 2010, Pages 344-354

  Murphy Ryan, Maureen ^a   Psychogios, Apostolos ^b   Lindor, Noralane M ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

aneurysm; aorta; connective tissue; dissection; vascular disease

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ALOPECIA; ARTERIAL TORTUOSITY SYNDROME; ARTERY DISSECTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; BICUSPID AORTIC VALVE; CAMPTODACTYLY; CAMURATI ENGELMANN DISEASE; CATSHL SYNDROME; CONGENITAL CONTRACTURAL ARACHNODACTYLY; CUTIS LAXA; DIFFERENTIAL DIAGNOSIS; ECTOPIA LENTIS; EHLERS DANLOS SYNDROME; FRAGILE X SYNDROME; HEARING LOSS; HEREDITARY CONNECTIVE TISSUE DISEASE; HOMOCYSTINURIA; HUMAN; LOEYS DIETZ SYNDROME; LUJAN FRYNS SYNDROME; MACROCEPHALY; MACS SYNDROME; MARFAN SYNDROME; MITRAL VALVE PROLAPSE; PATENT DUCTUS ARTERIOSUS; SCOLIOSIS; SHPRINTZEN GOLDBERG SYNDROME; SNYDER ROBINSON SYNDROME; STICKLER SYNDROME; SYNDROME; TALL STATURE; THORACIC AORTA ANEURYSM; WEILL MARCHESANI SYNDROME; X CHROMOSOME LINKED DISORDER;

CONNECTIVE TISSUE; DIAGNOSIS, DIFFERENTIAL; GUIDELINES AS TOPIC; HUMANS; MARFAN SYNDROME;

EID: 77953960235     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181e074f0     Document Type: Article

References (101)

1. Pyeritz R, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med 1979;300:772-777.
2. Summers KM, West JA, Peterson MM, Stark D, McGill JJ, West MJ. Challenges in the diagnosis of Marfan syndrome. Med J Aust 2006;184:627-631.
3. Pearson GD, Devereux R, Loeys B, et al. Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation 2008; 118:785-791.
4. Callewaert B, Malfait F, Loeys B, De Paepe A. Ehlers-Danlos syndromes and Marfan syndrome. Best Pract Res Clin Rheumatol 2008;22:165-189.
5. Mizuguchi T, Matsumoto N. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. J Hum Genet 2007;52:1-12.
6. Argraves WS, Greene LM, Cooley MA, Gallagher WM. Fibulins: physiological and disease perspectives. EMBO Rep 2003;4:1127-1131.
7. Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metallo-proteinases. Biochem J 2005;386(Pt 1):15-27.
8. Whiteman P, Hutchinson S, Handford PA. Fibrillin-1 misfolding and disease. Antioxid Redox Signal 2006;8:338-346.
9. Kuivaniemi H, Shibamura H, Arthur C, et al. Familial abdominal aortic aneurysms: collection of 233 multiplex families. J Vasc Surg 2003;37:340-345.
10. Faiyaz-Ul-Haque M, Zaidi SH, Wahab AA, et al. Identification of a p.Ser81Arg encoding mutation in SLC2A10 gene of arterial tortuosity syndrome patients from 10 Qatari families. Clin Genet 2008;74:189-193.
11. Faiyaz-Ul-Haque M, Zaidi SH, Al-Sanna N, et al. A novel missense and recurrent mutation in SLC2A10 gene of patients affected with arterial tortuosity syndrome. Atherosclerosis 2009;203:466-471.
12. Davies RR, Kaple RK, Mandapati D, et al. Natural history of ascending aortic aneurysm in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg 2007;83:1338-1344.
13. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-274.
14. Garg V. Molecular genetics of aortic valve disease. Curr Opin Cardiol 2006;21:180-184.
15. McKellar SH, Tester DJ, Yagubyan M, Majumdar R, Ackerman MJ, Sundt TM III. Novel NOTCH1 mutations in patients with bicuspid aortic valve disease and thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2007; 134:290-296.
16. Tadros TM, Klein MD, Shapiro OM. Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation 2009;119:880-890.
17. Janssens K, Vanhoenacker F, Bonduelle M, et al. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet 2006; 43:1-11.
18. Toydemir RM, Brassington AE, Bayrak-Toydemir P, et al. A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome. Am J Hum Genet 2006;79:935-941.
19. Wang M, Clericuzio CL, Godfrey M. Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2. Am J Hum Genet 1996;59:1027-1034.
20. Callewaert BL, Loeys BL, Ficcadenti A, et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arach-nodactyly: report of 14 novel mutations and review of the literature. Hum Mutat 2009;30:334-341.
21. Frédéric MY, Monino C, Marschall C, et al. The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. Hum Mutat 2009;30:181-190.
22. Nishimura A, Sakai H, Ikegawa S, et al. FBN2, FBN1, TGFBR1, and TGFBR2 analyses in congenital contractural arachnodactyly. Am J Med Genet A 2007;143:694-698.
23. Graul-Neumann LM, Hausser I, Essayie M, Rauch A, Kraus C. Highly variable cutis laxa resulting from a dominant splicing mutation of the elastin gene. Am J Med Genet A 2008;146A:977-983.
24. Rodriguez-Revenga L, Iranzo P, Badenas C, Puig S, Carrio A, Mila M. A novel elastin gene mutation resulting in an autosomal dominant form of cutis laxa. Arch Dermatol 2004;140:1135-1139.
25. Szabo Z, Crepeau MW, Mitchell AL, et al. Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene. J Med Genet 2006;43:255-258.
26. Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z. Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 2006;78:1075-1080.
27. Morava E, Guillard M, Lefeber DJ, Wevers RA. Autosomal recessive cutis laxa syndrome revisited. Eur J Hum Genet 2009;17:1099-1100.
28. Morava E, Lefeber D, Urban Z, et al. Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Eur J Hum Genet 2008;16:28-35.
29. Guernsey DL, Jiang H, Evans SC, et al. Mutation in pyrroline-5-carboxy- late reductase 1 gene in families with cutis laxa type 2. Am J Hum Genet 2009;85:120-129.
30. Reversade B, Escande-Beillard N, Dimopoulou A, et al. Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet2009;41:1016-1021.
31. Kornak U, Reynders E, Dimopoulou A, et al. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet 2008;40:32-34.
32. Ali M, McKibbin M, Booth A, et al. Null mutations in LTBP2 cause primary congenital glaucoma. Am J Hum Genet 2009;84:664-671.
33. Ahram D, Sato TS, Kohilan A, et al. A homozygous mutation in AD-AMTSL4 causes autosomal-recessive isolated ectopia lentis. Am J Hum Genet 2009;84:274-278.
34. Attias D, Stheneur C, Roy C, et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation 2009;120:2541-2549.
35. Byers PH, Duvic M, Atkinson M, et al. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen. Am J Med Genet 1997;72:94-105.
36. Schwarze U, Hata R, McKusick VA, et al. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. Am J Hum Genet 2004;74:917-930.
37. Malfait F, Symoens S, Coucke P, Nunes L, De Almeida S, De Paepe A. Total absence of the alpha2(1) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems. J Med Genet 2006;43:E36.
38. Malfait F, De Paepe A. Molecular genetics in classics Ehlers-Danlos Syndrome. Am J Med Genet C Semin Med Genet 2005;139C:17-23.
39. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77:31-37.
40. Malfait F, De Coster P, Hausser I, et al. The natural history, including orofacial features of three patients with Ehlers-Danlos syndrome, dermatosparaxis type (EDS type VIIC). Am J Med Genet A 2004;131: 18-28.
41. Colige A, NuytinckL, Hausser I, et al. Novel types of mutation responsible for the dermatosparactic type of Ehlers-Danlos syndrome (Type VIIC) and common polymorphisms in the ADAMTS2 gene. J Invest Dermatol 2004; 123:656-663.
42. Voermans NC, van Engelen BG. Differential diagnosis of muscular hypotonia in infants: the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI). Neuromuscul Disord 2008;18:906-907.
43. Yiçs U, Dirik E, Chambaz C, Steinmann B, Giunta C. Differential diagnosis of muscular hypotonia in infants: the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VI). Neuromuscul Disord 2008;18:210-214.
44. Salavoura K, Valari M, Kolialexi A, Mavrou A, Kitsiou S. A case of Ehlers Danlos syndrome type VI. Genet Couns 2006;17:291-294.
45. Coman DJ. The congenital disorders of glycosylation are clinical chameleons. Eur J Hum Genet 2008;16:2-4.
46. Faiyaz-Ul-Haque M, Zaidi SH, Al-Ali M, et al. A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers-Danlos syndrome resembling the prog-eroid type. Am J Med Genet A 2004;128A:39-45.
47. Giunta C, Elçioglu NH, Albrecht B, et al. Spondylocheiro dysplastic form of the Ehlers-Danlos Syndrome\an autosomal-recessive entity caused by mutations in the zinc transporter gene SLC39A13. Am J Hum Genet 2008;82:1290-1305.
48. Germain DP. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg 2002;16:391-397.
49. Snead MP, Yates JR, Williams R, Payne SJ, Pope FM, Scott JD. Stickler syndrome type 2 and linkage to the COL11A1 gene. Ann N Y Acad Sci 1996;785:331-332.
50. Plancke A, Holder-Espinasse M, Rigau V, Manouvrier S, Claustres M, Van Kien PK. Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome. Eur J Hum Genet 2009;17:1411-1416.
51. Loeys BL, Schwarze U, Holm T, et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006;355:788-798.
52. Voermans NC, van Alfen N, Pillen S, et al. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol 2009;65:687-697.
53. Bristow J, Carey W, Egging D, Schalkwijk J. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet 2005;139C:24-30.
54. Schalkwijk J, Zweers MC, Steijlen PM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001;345:1167-1175.
55. Lindor NM, Bristow J. Tenascin-X deficiency in autosomal recessive Ehlers-Danlos syndrome. Am J Med Genet A 2005;135:75-80.
56. Vaughan C, Casey M, He J, et al. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 2001;103:2469-2475.
57. Guo DC, Pannu H, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007;39:1488-1493.
58. Tran-Fadulu VT, Pannu H, Kim DH, et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 2009;46:607-613.
59. Milewicz DM, Guo DC, Tran-Fadulu V, et al. Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 2008;9:283-302.
60. Davids JR, Hagerman RJ, Eilert RE. Orthopaedic aspects of fragile-X syndrome. J Bone Joint Surg Am 1990;72:889-896.
61. Hjalgrim H, Fisher Hansen B, Brondum-Nielson K, et al. Aspects of skeletal development in fragile X syndrome fetuses. Am J Med Genet 2000;95:123-129
62. Garber KB, Visootsak J, Warren ST. Fragile X Syndrome. Eur J Hum Genet 2008;16:666-672.
63. Yap S. Classical homocystinuria: vascular risk and its prevention. J Inherit Metab Dis 2003;26:259-265.
64. Salo AM, Cox H, Farndon P, et al. A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene. Am J Hum Genet 2008;83:495-503.
65. Akutsu K, Morisaki H, Takeshita S, et al. Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-receptor genes. Circ J 2007;71:1305-1309.
66. Lerma-Carrillo I, Molina JD, Cuevas-Duran T, et al. Psychopathology in the Lujan-Fryns syndrome: report of two patients and review. Am J Med Genet A 2006;140:2807-2811.
67. Van Buggenhout G, Fryns JP. Lujan-Fryns syndrome (mental retardation, X-linked, marfanoid habitus). Orphanet J Rare Dis 2006;1:26.
68. Stathopulu E, Ogilvie CM, Flinter FA. Terminal deletion of chromosome 5p in a patient with phenotypical features of Lujan-Fryns syndrome. Am J Med Genet A 2003;119A:363-366.
69. Schwartz CE, Tarpey PS, Lubs HA, et al. The original Lujan syndrome family has a novel missense mutation (p.N1007S) in the MED12 gene. J Med Genet 2007;44:472-477.
70. Blazek E, Mittler G, Meisterernst M. The mediator of RNA polymerase II. Chromosoma 2005;113:399-408.
71. Tarpey PS, Raymond FL, Nguyen LS, et al. Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syn-dromic and nonsyndromic mental retardation. Nat Genet 2007;39:1127-1133.
72. Basel-Vanagaite L, Sarig O, Hershkovitz D, et al. RIN2 deficiency results in macrocephaly, alopecia, cutis laxa, and scoliosis: MACS syndrome. Am J Hum Genet 2009;85:254-263.
73. De Paepe A, Devereux R, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62: 417-426.
74. Comeglio P, Johnson P, Arno G, et al. The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations. Hum Mutat 2007;28:928.
75. Putnam EA, Cho M, Zinn AB, Towbin JA, Byers PH, Milewicz DM. Delineation of the Marfan phenotype associated with mutations in exons 23-32 of the FBN1 gene. Am J Med Genet 1996;62:233-242.
76. Pepe G, Giusti B, Evangelisti L, et al. Fibrillin-1 (FBN1) gene frameshift mutations in Marfan patients: genotype-phenotype correlation. Clin Genet 2001;59:444-450.
77. De Backer J, Loeys B, Leroy B, Coucke P, Dietz H, De Paepe A. Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome. Clin Genet 2007;72:188-198.
78. Glesby MJ, Pyeritz RE. Association of mitral valve prolapse and systemic abnormalities of connective tissue: a phenotypic continuum. JAMA 1989; 262:523-528.
79. Freed LA, Levy D, Levine RA, et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341:1-7.
80. Grau JB, Pirelli L, Yu PJ, Galloway AC, Ostrer H. The genetics of mitral valve prolapse. Clin Genet 2007;72:288-295.
81. Khau Van Kien P, Wolf JE, Mathieu F, et al. Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity. Eur J Hum Genet 2004;12:173-180.
82. KhauVan Kien P, Mathieu F, Zhu L, et al. Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosis to 16p12.2-p13.13. Circulation 2005;112:200-206.
83. Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 2006;38:343-349.
84. Zhu L, Bonnet D, Boussion M, Vedie B, Sidi D, Jeunemaitre X. Investigation of the MYH11 gene in sporadic patients with an isolated persistently patent arterial duct. Cardiol Young 2007;17:666-672.
85. van Steensel MA, van Geel M, Parren LJ, Schrander-Stumpel CT, Marcus-Soekarman D. Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2. Exp Dermatol 2008;17:362-365.
86. Sood S, Eldadah ZA, Krause WL, McIntosh I, Dietz HC. Mutations in fibrillin-1 and the Marfanoid-craniosynostosis (Shprintzen-Goldberg) syndrome. Nat Genet 1996;12:209-211.
87. Kosaki K, Takahashi D, Udaka T, et al. Molecular pathology of Shprintzen-Goldberg syndrome. Am J Med Genet A 2006;140:104-108.
88. Robinson PN, Neumann LM, Demuth S, et al. Shprintzen-Goldberg syndrome: fourteen new patients and a clinical analysis. Am J Med Genet A 2005;135:251-262.
89. Becerra-Solano LE, Butler J, Castanedo-Cisneros G, et al. A missense mutation, p.V132G, in the X-linked spermine synthase gene (SMS) causes Snyder-Robinson syndrome. Am J Med Genet A 2009;149A:328-335.
90. Cason AL, Ikeguchi Y, Skinner C, et al. X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome. Eur J Hum Genet 2003;11:937-944.
91. de Alencastro G, McCloskey DE, Kliemann SE, et al. New SMS missense mutation leads to a striking reduction in spermine synthase protein function and a severe form of Snyder-Robinson X-linked recessive mental retardation syndrome. J Med Genet 2008;45:539-543.
92. Liberfarb RM, Levy HP, Rose PS, et al. The Stickler syndrome: genotype/phenotype correlation in 10 families with Stickler syndrome resulting from seven mutations in the type II collagen gene locus COL2A1. Genet Med 2003;5:21-27.
93. Martin S, Richards AJ, Yates JR, Scott J, Pope M, Snead MP. Stickler syndrome: further mutations in COL11A1 and evidence for additional locus heterogeneity. Eur J Hum Genet 1999;7:807-814.
94. Donoso LA, Edwards AO, Frost AT, et al. Clinical variability of Stickler syndrome: role of exon 2 of the collagen COL2A1 gene. Surv Opthalmol 2003;48:191-203.
95. Sirko-Osadsa DA, Murray MA, Scott JA, Lavery MA, Warman ML, Robin NH. Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the alpha2(XI) chain of type XI collagen. J Pediatr 1998;132:368-371.
96. Dagoneau N, Benoist-Lasselin C, Huber C, et al. ADAMTS10 mutations in autosomal recessive Weill-Marchesani syndrome. Am J Hum Genet 2004; 75:801-806.
97. Faivre L, Dollfus H, Lyonnet S, et al. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Am J Med Genet A 2003; 123A:204-207.
98. Kojuri J, Razeghinejad MR, Aslani A. Cardiac findings in Weill-Marchesani syndrome. Am J Med Genet A 2007;143A:2062-2064.
99. Armstrong L, Graham GE, Schimke RN, et al. The Hunter-MacDonald syndrome with expanded phenotype including risk of meningioma: an update and review. Am J Med Genet A 2008;146A:83-92.
100. Gelb BD. Marfan's syndrome and related disorders\more tightly connected than we thought. N Engl J Med 2006;355:841-844.
101. Matt P, Habashi J, Carrel T, Cameron DE, Van Eyk JE, Dietz HC. Recent advances in understanding Marfan syndrome: should we now treat surgical patients with losartan? J Thorac Cardiovasc Surg 2008;135:389-394.